The company, Celgene UK, has informed NICE that they are unable to provide an evidence submission at this time and will work with us to reschedule. Therefore, we are suspending the appraisal whilst we consider the next steps.
Therefore the discussion of this appraisal at the committee meeting in July 2020 has been cancelled.
Status | Suspended |
Decision | Selected |
Process | STA 2018 |
ID number | 1550 |
Project Team
Project lead | Jeremy Powell |
Email enquiries
- If you have any queries please email tacommb@nice.org.uk
External Assessment Group | School of Health and Related Research (ScHARR), University of Sheffield |
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
06 February 2020 | Suspended. The company, Celgene UK, has informed NICE that they are unable to provide an evidence submission at this time and will work with us to reschedule. Therefore, we are suspending the appraisal whilst we consider the next steps. Therefore the discussion of this appraisal at the committee meeting in July 2020 has been cancelled. |
07 November 2019 | Invitation to participate |
07 November 2019 | In progress |
28 May 2019 - 25 June 2019 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual